[go: up one dir, main page]

Procedure For Alerts and Modifications - AOC

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

Procedure For Alerts and Modifications of Medical Devices

PRO/06
Approved by: Signature:
General Manager
-------------------------------------------
Original date: Version: Next Review Due on:
25th October 2021 1st 25th October 2022

PURPOSE

 The purpose of this procedure is to describe and retain the documentation of the
actions that take place once an Alert and Modification notice is issued from the
manufacturer.

Definition

 Modification from manufacturer can be changes in manufacturing process of the


medical device or the design, the materials, changes in sterilization that may
unintentionally affect device performance or software upgrading or releasing a
new model or updated version of medical device

SCOPE

 This procedure is applicable to all the medical devices/products delivered by


“Ammar Optician Company W.L.L” within the Kingdom of Bahrain.

RESPONSIBILTIES

 The company will depend on the manufacturer/principle to issue the Alert and
Modification notice.
 Every alert/modification notice issued from the manufacturer/principle for
existing devices in the Kingdom of Bahrain must be communicated to NHRA by
the maintenance team, after the approval of the General Manager.
 In the cases, where modification notice of a device/product affects the safety of
the medical device /product, the company will also submit reasons for
modification and the details to NHRA.
 Maintenance team must ensure that the end users receive a copy of the
alert/modification notice.

1
 Maintenance team will withdraw the affected device from the Bahrain market and
hand it over to the store for storage until the corrective action is implemented.
 Storekeeper will be responsible for affixing the “For Modification-Quarantine”
label to each medical device that has been recovered from the market and store it
in a separate storage area.

PROCEDURE

 The maintenance team will receive and log the modification/alert notice from the
manufacturer and communicate it to the storekeeper and the office department to
verify if the relevant products/devices are in stock.
 The storekeeper will trace the devices from the company’s software DOTLINE
TECHNOLOGY system (against their serial numbers, lot/batch numbers etc.) to
recall them for any modification or withdrawal. The details entered into the
system will be, but not limited to the following:
1. Medical Device/Product name
2. Model
3. Serial Number
4. Batch Number
5. Lot Number
6. Manufacturer details
7. Country of Origin
8. Quantity
9. Price/Cost
10. End user details
11. Recall/adverse event/alert and modification record
12. Service reports/PPM
 The storekeeper will submit a list of the product/device that are already in the
shelf to the maintenance team.
 Any alert/modification notice received by the company, that could affect
significantly the safety and effectiveness of a device, or change the device's
intended use, requires the submission of full details about the medical device and
reasons of modification to NHRA.
 End users must be notified about the Alert/Modification within:
 02 Working days if alert/modification is categorized as Very High Risk
 05 Working days if alert/modification is categorized as High Risk
 10 Working days if alert/modification is categorized as Medium Risk

 All the goods which are returned from end users or from store shelf will be
considered as “Non acceptable returned goods” and they shall be placed in a

2
separate area in the store with the label fixed to them that reads, “For
modification –Quarantine” so they do not get mixed with the regular goods.
 Maintenance team will communicate with the manufacturer to determine the
corrective action plan and, whatever corrective action plan the manufacturer
shares, will be implemented and the goods will be returned to the end users/
customers and returned back to the Bahrain market as well.
 After follow up with the manufacturer’s instruction, the goods will be returned to
end users/customers, and will start to be available again in the Bahrain market.
 In case the modifications of a medical device could affect significantly the safety
and effectiveness of a device, or change the device's intended use, it would
require the submission of full details and reasons of modification to NHRA
through the company.
 Corrective action for the alert/modification should be documented and a closure
report containing the detailed corrective action taken by the company should be
submitted to NHRA.

REVIEW

 This policy shall be reviewed on an annual basis for any modifications and
iterations in the process.

ATTACHMENTS

 Alert & Modification Form (separately attached)


 Label Quarantine- Modified Goods (attached below)

3
Medical device/Product:

Date of Expiry

Serial Number:

Batch Number:
Quarantine- FSN No.

For Modification Quantity:

Reason:

You might also like